de Lissovoy G, Zenilman J, Nelson KE, Ahmed F, Celentano DD. The cost of a preventable disease: estimated U.S. national medical expenditures for congenital syphilis, 1990. Public Health Rep 1995;110:403-9.

Drug Topics Red Book. Montvale, NJ: Medical Economics Company, Inc., 1995.


Ebrahim SH, Peterman TA, Zaidi AA, Kamb ML. Mortality related to sexually transmitted diseases in women, U.S., 1973-1992. Eleventh Meeting of the International Society for STD Research, August 27-30, 1995, New Orleans, LA [abstract no. 343].


Fish RM. Herpes simplex. In: Fish RM, Campbell ET, Trupin SR, eds. Sexually transmitted diseases: problems in primary care. Los Angeles: Practice Management Information Corporation, 1992.


Grimes DA. Deaths due to sexually transmitted diseases: the forgotten component of reproductive mortality. JAMA 1986;255:1727-9.


Hall CB, Halsey NA. Control of hepatitis B: to be or not to be? Pediatrics 1992;90 [2 Pt. 1] 274-7.

Hellinger FJ. Forecasts of the costs of medical care for persons with HIV: 1992-1995. Inquiry 1992;29:356-65.

Hibbs JR, Gunn RA. Public health intervention in a cocaine-related syphilis outbreak. Am J Public Health 1991;81:1259-62.


IMS America. National disease and therapeutic index (NDTI). Plymouth Meeting, PA: IMS America, 1993.

IOM (Institute of Medicine). New vaccine development: establishing priorities; vol. I, Diseases of importance in the United States. Washington, D.C.: National Academy Press, 1985.


Johnson RE, Nahmias AJ, Magder LS, Lee FK, Broods CA, Snowden CB. A seroepidemiologic survey of the prevalence of herpes simplex virus type 2 infection in the United States . N Engl J Med 1989;321:7-12.


Margolis HS, Alter MJ, Hadler SC. Hepatitis B: evolving epidemiology and implications for control. Semin Liver Dis 1991;11:84-92.

Margolis HS, Coleman PJ, Brown RE, Mast EE, Sheingold SH, Arevalo JA. Prevention of hepatitis B virus transmission by immunization. An economic analysis of current recommendations. JAMA 1995;274:1201-8.

Moran JS, Kaufman JA, Felsenstein D. Survey of health care providers: who sees patients needing STD services, and what services do they provide? Sex Transm Dis 1995;22:67-9.


NIH (National Institutes of Health). Disease-specific estimates of direct and indirect costs of illness and NIH support. Draft document, February 1995.


Oriel D. Genital human papillomavirus infection. In: Holmes KK, Mårdh P-A, Sparling PF, Wiesner PJ, Cates W Jr., Lemon SM, Stamm WE, eds. Sexually transmitted diseases. 2nd ed. New York: McGraw-Hill, 1990.


Paavonen J, Koutsky LA, Kiviat N. Cervical neoplasia and other STD-related genital and anal neoplasms. In: Holmes KK, Mårdh P-A, Sparling PF, Wiesner PJ, Cates W Jr., Lemon SM, et al., eds. Sexually transmitted diseases. 2nd ed. New York: McGraw-Hill, 1990.


Randolph AG, Washington AE, Prober CG. Cesarean delivery for women presenting with genital herpes lesions: efficacy, risks, and costs. JAMA 1993;270:77-82.

Reeves WC, Rawls WE, Brinton LA. Epidemiology of genital papillomaviruses and cervical cancer. Rev Infect Dis 1989;11:426-39.

Rice DP, Hodgson TA, Kopstein AN. The economic costs of illness: a replication and update. Health Care Financ Rev 1985;7:61-80.


Schiffman MH, Bauer HM, Hoover RN, Glass AG, Cadell DM, Rush BB, et al. Epidemiologic evidence showing that human papillomavirus infection causes most cervical intraepithelial neoplasia. J Natl Cancer Inst 1993;85:958-64.

Schmid GP, Sanders LL, Blount JH, Alexander ER. Chancroid in the United States: re-establishment of an old disease. JAMA 1987;258:3265-8.



The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement